Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do we need another antihypertensive agent?

R Gorlin1

  • 1Department of Medicine, Mount Sinai Medical Center, New York, NY 10029.

American Heart Journal
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physiologic Evaluation of Patients with Mitral Stenosis before and After Mitral Valvuloplasty.

Transactions of the American Clinical and Climatological Association·2011
Same author

Morning panel discussion.

Bulletin of the New York Academy of Medicine·2009
Same author

Analysis of the p63 gene in classical EEC syndrome, related syndromes, and non-syndromic orofacial clefts.

Journal of medical genetics·2002
Same author

Cultural collisions at the bedside: social expectations and value triage in medical practice.

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2001
Same author

Advances in cardiology: the complementary roles of concept and technology.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·1998
Same author

Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects.

The Journal of clinical endocrinology and metabolism·1998
Same journal

Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

American heart journal·2026
Same journal

Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

American heart journal·2026
Same journal

Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

American heart journal·2026
Same journal

Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

American heart journal·2026
Same journal

THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

American heart journal·2026
Same journal

DOAC Score Among Patients Receiving Vitamin K Antagonists.

American heart journal·2026
See all related articles

Selecting antihypertensive medications requires balancing effectiveness with side effects and patient tolerability. Newer considerations include how these drugs impact other health conditions, necessitating diverse treatment options.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Clinical Therapeutics

Background:

  • Traditionally, antihypertensive agent selection focused on efficacy versus adverse effects.
  • Patient tolerability and compliance are crucial for effective treatment regimens.
  • Emerging considerations involve the impact of antihypertensives on comorbid conditions.

Purpose of the Study:

  • To explore the multifaceted criteria for selecting antihypertensive agents.
  • To highlight the evolving landscape of antihypertensive drug considerations.
  • To underscore the need for a broader pharmacologic armamentarium.

Main Methods:

  • Review of existing literature on antihypertensive pharmacology and clinical practice.
  • Analysis of factors influencing drug selection, including efficacy, safety, and tolerability.

Related Experiment Videos

  • Evaluation of the impact of antihypertensive agents on associated disease states.

    • Main Results:

    • A variety of agents can achieve therapeutic efficacy, alone or in combination.
    • Adverse effects and patient tolerability significantly influence treatment compliance.
    • Antihypertensive drugs' effects on conditions like diabetes, gout, and atherosclerosis are critical new factors.

    Conclusions:

    • Antihypertensive agent selection necessitates a comprehensive approach beyond efficacy and safety.
    • Patient-centered factors like tolerability are paramount for treatment success.
    • The influence on comorbid conditions drives the development of novel antihypertensive therapies.